Track topics on Twitter Track topics that are important to you
Here are the most relevant search results for "PotNetwork Holding" found in our extensive news archives from over 250 global news sources.
In addition to our news stories we have dozens of PubMed Articles about PotNetwork Holding for you to read. Along with our medical data and news we also list PotNetwork Holding Clinical Trials, which are updated daily. BioPortfolio also has a large database of PotNetwork Holding Companies for you to search.
Edison Investment Research - Pharmaceutical & healthcare - Auris Medical Holding: Auris Medical recently reported its Q318 results and provided a brief business update on its active programs. R&D expenditure for the period was down roughly 60% over Q317, which reflects management’s swift pivot to focus on Phase I development. Auris plans to initiate two intranasal betahistine trials in Q...
Edison Investment Research - Investment trusts - Princess Private Equity Holding: Princess Private Equity Holding (PEY) recorded a particularly high level of investment activity in FY18 (to 31 December), following on from a record year of realisations in FY17. The fund focuses on profitable companies with: a consistent track record of EBITDA growth (an average of 11.5% for 2018 across the whole po...
Oslo (Norway), 17 October 2018 - Exercise of employee share options, mandatory notification of trade and resolution to increase the share capital in PCI Biotech Holding ASA (the "Company"). 1. Opti...
$GLPG Sands Capital reports 5.7% holding
Mechelen, Belgium; 8 January 2019; 22.01 CET; regulated information - Galapagos NV (Euronext & NASDAQ: GLPG) received a transparency notification from Sands Capital Management, LLC. Pursuant to Belgian transparency legislation, Galapagos received a transparency notification on 27 December 2018 from Sands Capital Management, LLC, who notified that it held 3,092,264 of Galapagos' vo...
Company Announcement No. 24/2018November 29, 2018 For further information please contact:Martin Riise, Senior Director, Investor Relations, Tel: +45 5339 2250Camilla Lercke, Head of Media Relations, Tel: +45 5339 2384 About Chr. HansenChr. Hansen is a leading global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricult...
Move to Bermuda will enhance corporate flexibility, reduce costs and provide better alignment with U.S. corporate law Subject to approval by extraordinary general meeting of shareholders Zug, Switzerland, January 29, 2019 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology an...
Dermapharm Holding SE / Key word(s): Investment Dermapharm Holding SE acquires a stake in cannabis producer for pharmaceutical applications 04-March-2019 / 17:51 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. D...
baker bros gonna take a huge hit on $SGEN their largest holding by far 28% position
Put down the cat, coffee, beer pint, martini, whatever you're holding, and make sure you've updated Chrome (unless you enjoy being hacked) The RegisterGoogle warns users to immediately update Chrome browser after critical bug discovered The TelegraphUpdate your Google Chrome NOW – tech giant warns over dangerous bug ‘that lets hackers hijack your com The SunStop What You're Doing and Update...